2 dividend heroes with yields over 5% I’d buy now

These two stocks have high dividend yields and here’s why I think they can maintain them.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

High dividend yields aren’t always a good thing. We all want to chase the highest paying stock, but sometimes that isn’t the best course of action. That’s because struggling companies might boost the yield to attract investors and sometimes the yield is high simply because the share price has fallen due to the company struggling.

So dividend sustainability is key. Can the business afford its dividend or is a cut on the horizon? A company’s recent history will tell you whether the dividend is sustainable and if the stock is worth your money. Here are two I think are worth the price.

Pharmaceutical giant

GlaxoSmithKline (LSE: GSK) is my first pick, with its tempting dividend yield of 5.5%. It is currently priced at around 1,600p with a P/E ratio of around 20, not the best-looking P/E in the world, but I believe that even with its high price it can still reward investors. GlaxoSmithKline has steadily been paying dividend yields of around 5% to 6% for years now, reliably paying around 80p per share year after year. This reassures me that, despite market fluctuations, GSK can still bring in the money.

Such a high dividend could fluctuate, but CFO Iain MacKay has confirmed GSK’s commitment to the yield for this year. And the future? It has many products that are seeing great results with Ellipta respiratory sales climbing 20% and Nucala seeing 40% growth in Q1 this year. The company has three main areas of income that provide a safety net: consumer healthcare, vaccines and pharmaceuticals. Vaccines sales soared in Q1 due to the Shingrix shingles treatment. This vaccine accounted for £365m of sales, up from £110m in Q1 of 2018, which is more than a fifth of all vaccine revenue for the firm. Vaccine sales as a whole were up 23% in Q1. This huge amount of cash flow helps sustain a healthy dividend yield I believe is worth paying a high price for.

Reality show

ITV (LSE: ITV) is my next pick, with its mouthwatering yield of 7.6%. ITV shares are currently priced around 106p with a P/E ratio of 11.9. That ratio is lower than the UK average and the company has reasonable long-term debt levels of £981m with £424m operating cash flow in the last 12 months. This means an operating-cash-to-total-debt ratio of 40%, demonstrating how the debt is significantly covered.

ITV did well in Q1. Despite total national television viewers dropping 3%, its share of these views rose 24%. Registered ITV hub users have also risen by 29% this year, with statistics showing that there’s at least one ITV hub account in every UK household. These figures highlight how the company has an in-depth share of (and insight into) our TV habits. This is important as it plans to launch targeted ads on the hub accounts that should hopefully boost revenue this year, reassuring investors, despite the challenging TV advertising market.

Furthermore, the return of Love Island has also seen a huge boost in viewership, keeping ITV ahead during prime time TV hours. That upcoming launch of ITV hub tailored ads and an admittedly-modest 1% increase in revenues in Q1 shows the company has growth prospects ahead. With ITV stock prices being so low and a healthy dividend, I think that this undervalued investment is far too tempting to ignore. 

fional has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended ITV. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman with tablet, waiting at the train station platform
Investing Articles

Down 21% in less than 2 months, this FTSE small-cap stock’s worth a look today

Despite rising 8% yesterday, this 177p growth stock from the FTSE AIM 100 Index is significantly lower than where it…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Down 78% with a P/E of 6.5, is this a rare chance to buy a cheap UK share?

The stock of this FTSE 250 finance provider trades on a multiple of close to six. Does this make it…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

4 great reasons to consider BAE Systems shares today!

BAE Systems shares have surged more than a third in value over the past year. Can the FTSE 100 company…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Why I’m worried about this hidden risk causing a stock market crash

Global markets have been rattled by the Iran war and surging oil prices. Ken Hall thinks there's another risk hiding…

Read more »

Three generation family are playing football together in a field. There are two boys, their father and their grandfather.
Investing Articles

An unmissable chance to get an eye-popping second income from FTSE shares?

Harvey Jones says investors hunting for a generous second income from FTSE 100 dividend stocks may find that now's a…

Read more »

Workers at Whiting refinery, US
Investing Articles

£5,000 worth of BP shares bought when the year began are now worth…

BP shares are on the up as global unrest sends oil prices skyrocketing. Our writer calculates this year's gains and…

Read more »

Man thinking about artificial intelligence investing algorithms
Dividend Shares

Down 23%, are Barclays shares back in the bargain bin?

Barclays shares have plunged by almost a quarter since their February high. However, higher energy prices could boost profits for…

Read more »

Investing Articles

I asked ChatGPT to settle the ISA v SIPP debate once and for all. It said…

Instead of working out whether an ISA or SIPP is the better tax wrapper, Harvey Jones called the robots in.…

Read more »